Navigation Links
Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice

Summary: Proprietary DNA delivery technology enables sustained Interferon-beta production from muscle cells - reduces atherosclerosis progression in mouse model of heart disease

NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Research conducted at Cleveland Clinic and presented today at the American College of Cardiology's 58th Annual Scientific Session showed that a single administration of DNA encoding the anti-inflammatory protein interferon-beta (IFN-beta) using Ichor Medical System's TriGrid Delivery System (TriGrid) reduced the development of plaque formation in a mouse model of atherosclerosis.

"The sustained production of this protein reduced the atherosclerotic lesion size and tissue-damaging inflammation that characterize the blood vessels of these mice with atherosclerosis," said Marc S. Penn, M.D., Ph.D., principal investigator from Cleveland Clinic.

While preliminary, these results broaden the support for the use of the electroporation-based TriGrid as an enabling platform technology to provide continuous endogenous production of therapeutic proteins from a patient's own muscle. Previous studies done in collaboration with Dr. Vince Tuohy's lab at Cleveland Clinic demonstrated that one-time delivery of the IFN-beta gene intramuscularly with the TriGrid in a mouse model of multiple sclerosis (MS), resulted in sustained production of IFN-beta and a similar reduction in the severity of clinical disease as compared to a separate group of mice dosed every other day with recombinant IFN-beta (Molecular Therapy 14(3): 416-422 (2006)). This study suggests that in vivo gene transfer of the IFN-beta gene may provide a convenient and viable alternative to constant life-long dosing of the recombinant form of IFN-beta for patients with MS.

Together, these data demonstrate both the potential therapeutic and economic value of Ichor's technology.

"The TriGrid platform makes treatments like
'"/>




Page: 1 2 3

Related medicine technology :

1. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
2. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
3. New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
4. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
5. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
6. First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. Point of Care Strep Tests Speed Treatment, Lower Costs
9. Rapid HIV Testing Increases Possibility of Treatment
10. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
11. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
Post Your Comments:
(Date:3/26/2015)... , March 26, 2015  The new Phonak CROS ... the unaidable ear to a Venture hearing aid worn on ... to hear speech from the side they could not hear ... is as easy and intuitive as a normal binaural fit, ... solution during the fitting session.    "Fitting single-sided ...
(Date:3/26/2015)... InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading ... healthcare industry in the United States ... secured a new $45.0 million credit facility with JPMorgan Chase ... facility with its prior lender group.  Effective ... senior secured credit agreement comprised of a $10.0 million asset-based ...
(Date:3/26/2015)... March 26, 2015 DePuy Synthes Companies ... Radlink, Inc., an emerging global leader in advanced ... with its hip replacement systems. The agreement further ... improve patient outcomes, increase patient satisfaction and reduce ... 81st annual meeting of the American Academy of ...
Breaking Medicine Technology:Phonak CROS II: The smart solution for single-sided deafness 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 3
... YORK, May 25, 2012  Delcath Systems, Inc. (NASDAQ: ... public offering of 13,333,340 shares of its common stock and ... at a combined price to the public of $1.50 per ... The warrants are exercisable at an exercise price of $1.65 ...
... and SÃO JERÔNIMO, Brazil, May 25, 2012 ... Limited (Osaka, Japan, "Takeda") and Multilab Indústria e ... Sul, Brazil, "Multilab") today jointly announced that both ... Brasil Ltda. (São Paulo, Brazil, "Takeda Brazil"), a ...
Cached Medicine Technology:Delcath Prices $20 Million Public Offering of Common Stock and Warrants 2Delcath Prices $20 Million Public Offering of Common Stock and Warrants 3Delcath Prices $20 Million Public Offering of Common Stock and Warrants 4Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 2Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 3Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 4
(Date:3/27/2015)... March 27, 2015 In light of ... number 1:15-cv-10429, U.S. District Court, District of Massachusetts; and ... Eastern District of Pennsylvania), the San Diego personal injury ... A.P.C. are announcing that they are available to investigate ... women who were prescribed Zofran while pregnant and who ...
(Date:3/26/2015)... Dallas, TX (PRWEB) March 26, 2015 ... of the 32nd annual Dallas Rhinoplasty Symposium and ... the years, reiterated the importance of evidence based medicine ... utilizing evidence from well conducted research. , "We often ... approaches to rhinoplasty, and while we are certainly not ...
(Date:3/26/2015)... Florida Hospital teamed up with ABC Action News to ... live Dr. Oz event, which took place at the Westfield ... thousand people came out to see Dr. Mehmet Oz and ... renowned cardiothoracic surgeon and Emmy award winning talk show host ... of experts for the live health expo. Florida Hospital physicians, ...
(Date:3/26/2015)... Old Tappan, NJ (PRWEB) March 26, 2015 ... research and statistical consulting firm, announced the release of ... by health experts to increase access to public restrooms ... recent trends in bathroom apps, BathroomMap does not facilitate ... a proprietary algorithm to identify and rate local establishments ...
(Date:3/26/2015)... 26, 2015 Dr. Alex Rabinovich and ... announce expanded offerings for Bay Area patients considering dental ... Center has long been a top-rated center, serving primarily ... to meet the strong demand by others throughout Northern ... a top-rated dental implant facility in San Francisco,”explained Dr. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3
... By Alan Mozes HealthDay Reporter , THURSDAY, March ... your computer hour after hour may well have its benefits, ... dry, tired eyes, blurred vision, fatigue and headaches. This ... eye experts don,t agree on whether it,s serious or even ...
... Sevan Goenezen holds the promise of becoming a powerful ... complex computational research has led to a fast, inexpensive ... differentiate between benign and malignant tumors with a high ... Department of Mechanical, Aerospace, and Nuclear Engineering at Rensselaer, ...
... March 3, 2011 Men living in low-income neighbourhoods consume ... compared to women in these neighbourhoods, according to a study ... findings, published in the Journal of Epidemiology and Community ... when it comes to alcohol consumption. Heavy drinking is associated ...
... March 3, 2010 Elsevier / Gold Standard, a ... announced today several enhancements to its pricing tool, ProspectoRx, ... to facilitate pricing analysis. The rate and ... environment make current, accurate and easily accessible pricing information ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, March ... people with both type 2 diabetes and heart disease -- ... maintain the blood sugar levels typical of people without diabetes ... 2 diabetes and heart disease by 19 percent, according to ...
... March 3, 2011 Patients with end-stage renal disease who ... infection than those who undergo hemodialysis, a retrospective study at ... is less costly, easier on the body and provides greater ... "Patients actually survive better on peritoneal dialysis, have a ...
Cached Medicine News:Health News:Computer Vision Syndrome: Fact or Fiction? 2Health News:Computer Vision Syndrome: Fact or Fiction? 3Health News:Student innovation at Rensselaer Polytechnic Institute could lead to better breast cancer screening 2Health News:Student innovation at Rensselaer Polytechnic Institute could lead to better breast cancer screening 3Health News:Men in low income neighborhoods drink more than women: Study 2Health News:Tight Blood Sugar Control May Put Some Diabetics at Risk 2Health News:Tight Blood Sugar Control May Put Some Diabetics at Risk 3Health News:Portable, less costly peritoneal dialysis shows no additional catheter risk factors 2
... III Model 8042 increases therapy versatility ... to optimize sensing, pacing and cardiac ... offers unmatched insight through key heart ... efficiently track a patient's clinical status. ...
... The OTI-Scan 3D is ... ultrasound system available today. ... B and A-scan system ... Macintosh desktop or laptop ...
... is an extremely accurate digital A-scan system. ... noise probe and fast precise algorithm enables ... probe along the visual axis. The A5500 ... CRT monitor, built-in thermal printer, 5 different ...
... advanced IOL workstation. Accurate, efficient and easy ... used with a variety of regressive, theoretical, ... the needs of the patient. Convenient design ... foot pedal for hands-free operation, audible tone ...
Medicine Products: